The MODUS Study is a feasibility study evaluating the safety and performance of hepatic (liver) denervation, renal (kidney) denervation or multi-organ (liver and kidney) denervation with Metavention’s iRF Denervation System for the treatment of type 2 diabetes and high blood pressure. Participants will receive one of these denervation treatments but will not know which one. This study is currently enrolling patients in Australia and has been approved by the Human Research Ethics Committee (HREC/60968/Alfred-2020).
To learn more about this study, please visit anzctr.org.au.
Am I a candidate for the MODUS study?
Do you have type 2 diabetes, high blood pressure, and...
- Are between the ages of 22 and 70?
- Currently take 0-3 medications for your type 2 diabetes and high blood pressure but would be interested in trying an alternative to medication?
- Willing to discontinue or change your current blood pressure medications if you were closely supervised?
IF YOU ANSWERED, “YES” TO ANY OF THESE QUESTIONS, YOU MAY BE ELIGIBLE TO PARTICIPATE IN THE MODUS CLINICAL STUDY.